Management of Neuropsychiatric Symptoms

Percentage of patients, regardless of age, with a diagnosis of dementia who have one or more neuropsychiatric symptoms who received or were recommended to receive an intervention for neuropsychiatric symptoms within a 12 month period

Date Reviewed: November 19, 2017
Do Not Support
    Group/Practice Individual Clinician

Measure Info

MIPS 284 CMS 284
Measure Type
Process
Measure Steward
American Academy of Neurology
Clinical Topic Area
Dementia
Care Setting
Outpatient
Data Source
Registry

ACP does not support QPP measure 284" "Dementia: Management of Neuropsychiatric Symptoms." Although this practice may help clinicians determine appropriate management of patients with dementia, there is a lack of high-quality evidence examining the impact of assessment on clinical outcomes or on appropriate assessment intervals. Also, implementation may result in overuse of pharmacologic therapy. Non- pharmacologic treatment modalities exist to manage neuropsychiatric symptoms, but implementation requires caregiver involvement. Furthermore, the numerator details do not specify a structured process for documentation of neuropsychiatric symptom assessment and the measure developers do not include reliability or validity data in the measure report.